Extracted from this filing and checked against the source text.
Listing & Compliance Notices
SEC 8-K Item 3.01
confidence 0.9
Scienture Holdings, Inc. received a nasdaq deficiency notice notice regarding other (rules 5550(a)(4)).
- Exchange
- nasdaq
- Notice
- deficiency notice
- Rules
- 5550(a)(4)
Exact text from the filing
June 23, 2023, the Listing Qualifications department of The Nasdaq Stock Market LLC (the “Nasdaq”) notified the Company that the Company was not in compliance with Nasdaq’s listing rules (the “Listing Rules”) as set forth in Listing Rule 5550(a)(4) given the Company’s failure to maintain a sufficient number of publicly held shares (the “Notice”). Citing the Company’s Event Form submitted to Nasdaq on June 7, 2023, Nasdaq calculated the Company’s publicly held shares as approximately 310,057 (which amount excludes shares held by officers, directors, or beneficial owners of 10 percent or more)
View on SEC.gov
Governance Changes
SEC 8-K Item 5.03/5.05/5.06
confidence 0.9
Scienture Holdings, Inc.: Filed Certificate of Designation for Series B Preferred Stock, setting forth terms including non-participating, no dividends, no liquidation preference, no voting rights, no redemption rights, and conversion upon stockholder approval into 100 shares of common stock each (effective 2023-06-26).
- Change
- charter amendment
- Effective
- 2023-06-26
Exact text from the filing
On June 26, 2023, the Company filed a Certificate of Designation, Preferences, Rights and Limitations of the Series B Preferred Stock with the Secretary of State of the State of Delaware (the “Certificate of Designation”).
View on SEC.gov